Gillis, Kevin D.
Liu, Xin A.
Marcantoni, Andrea
Carabelli, Valentina
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS048826)
National Institute of Mental Health (R01MH095046, R44MH096650)
San Paolo Foundation (CSTO 165284)
Italian Miur (2015 FNWP34)
Article History
Received: 26 July 2017
Revised: 21 August 2017
Accepted: 23 August 2017
First Online: 2 September 2017
Compliance with ethical standards
:
: Kevin D. Gillis has an ownership interest in ExoCytronics, LLC, which is developing commercial microfabricated devices for assaying quantal exocytosis.